Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
54.08 USD | +1.10% | +1.39% | -26.90% |
May. 23 | U.S. FDA advisers back approval for Guardant's cancer test | RE |
May. 21 | Exact Sciences Says Court Allows Patent Lawsuit Against Geneoscopy to Proceed | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.90% | 9.87B | |
-16.78% | 2.75B | |
-17.50% | 2.13B | |
-24.25% | 1.65B | |
+64.58% | 1.47B | |
+31.92% | 811M | |
-5.02% | 733M | |
-29.59% | 510M | |
+0.20% | 300M | |
-28.40% | 166M |
- Stock Market
- Equities
- EXAS Stock
- News Exact Sciences Corporation
- Piper Sandler Upgrades Exact Sciences to Overweight From Neutral, Price Target is $90